1. 2318 Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer. (September 2015) Authors: Jung, K.S.; Song, H.N.; Yoo, K.H.; Cho, J.; Kim, S.T.; Lee, J.; Park, S.H.; Park, Y.S.; Lim, H.Y.; Kang, W.K.; Park, J.O. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2337 Ramucirumab (RAM) as a second-line treatment in patients with advanced hepatocellular carcinoma (HCC) following first-line therapy with sorafenib in the randomized phase III REACH study: Analysis of alpha-fetoprotein (AFP) kinetics during treatment. (September 2015) Authors: Chau, I.; Park, J.O.; Ryoo, B.Y.; Yen, C.J.; Poon, R.; Pastorelli, D.; Blanc, J.F.; Kudo, M.; Pfiffer, T.F.; Hatano, E.; Chung, H.C.; Kubackova, K.; Phelip, J.M.; Brandi, G.; Ohkawa, S.; Li, C.P.; Okusaka, T.; Yang, L.; Abada, P.; Zhu, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2365 Nanoliposomal irinotecan (MM-398, nal-IRI) population pharmacokinetics (PK) and its association with efficacy and safety in patients with solid tumors based on the phase 3 study NAPOLI-1 and five phase 1 and 2 studies. (September 2015) Authors: Ma, W.W.; Chung, I.; Lang, I.; Csõszi, T.; Wenczl, M.W.; Cubillo, A.; Chen, J.; Wong, M.; Park, J.O.; Kim, J.S.; Rau, K.M.; Melichar, B.; Gallego, J.; Smakal, M.; Kim, J.; Belanger, B.; Bayever, E.; Adiwijaya, B. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S458 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Comparison of Folinic Acid, Fluorouracil and Irinotecan (FOLFIRI) plus Bevacizumab and FOLFIRI plus Aflibercept as Second-line Treatment for Metastatic Colorectal Cancer. Issue 8 (August 2022) Authors: Jo, H.; Lee, M.-S.; Lee, Y.-P.; Kim, H.; Hong, J.Y.; Lee, J.; Park, S.H.; Park, J.O.; Park, Y.S.; Lim, H.Y.; Kang, W.K.; Kim, S.T. Journal: Clinical oncology Issue: Volume 34:Issue 8(2022) Page Start: e323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Digital 3-Dimensional Liver Model Aids In Surgical Planning For Liver Tumors. (2020) Authors: Czerwonko, M.E.; Labadie, K.; Sullivan, K.; Park, J.O. Journal: HPB Issue: Volume 22(2020)Supplement 1 Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of adenosylcobalamin in relieving xerotic pruritus symptoms of atopic dermatitis. (18th March 2013) Authors: Kim, H.K.; Kim, B.J.; Suk, J.M.; Park, J.O.; Jung, S.W.; Sun, S.O.; Koo, J.; Lee, S.I. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 28:Number 2(2014:Feb.) Page Start: 254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor. (October 2022) Authors: Schram, A.; Borad, M.; Sahai, V.; Kamath, S.; Kim, R.; Liao, C.Y.A.; Oh, D.Y.; Ponz-Sarvisé, M.; Yachnin, J.; Shell, S.A.; Cassier, P.; Dotan, E.; Florou, V.; Moreno, V.; Park, J.O.; Tai, D.; Schmidt-Kittler, O.; Ferté, C.; Goyal, L.; Subbiah, V. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗